Federally-funded research is driving progress against cancer, according to the American Association for Cancer Research’s (AACR) 2017 Cancer Report which states that research has led to improved methods for detection, diagnosis, and treatment of the disease. The U.S. five-year relative survival rate for all cancers combined rose 20 percent over the last few decades. Despite these advances, the AACR says ongoing research is still necessary to address cancer health disparities and deepen our understanding of the contribution of biological factors such as genetics to the adverse health outcomes for certain populations. Additionally, costs of new global cancer cases are projected to reach $458 billion by the year 2030. The report calls on Congress to provide sustained and robust increases in investments in federal health agencies in the years ahead to fuel research and development. AACR will host a congressional briefing on the report on September 12 in the Rayburn House Office Building in Washington, D.C.